Indication Expansion Dynamics and Trial Characteristics of Novel Multi-Indication Anti-Cancer Drugs in China (2000–2024): A Cross-Sectional Study
Drug Design, Development and Therapy · 2026
DOI: 10.2147/dddt.s551402 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Drug Design, Development and Therapy, 2026. Verfasst von Xiaoyi Chen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, …. Hauptthemen laut MEDLINE: Antineoplastic Agents, Neoplasms. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Peo…
- Department of Pharmacy, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, People's Republic of Ch…
- Department of Pharmacy, The Fifth People's Hospital of Chengdu, Chengdu, Sichuan, People's Republic of China.
- Department of Pharmacy, The Second People's Hospital of Yibin, Yibin, Sichuan, People's Republic of China.
ORCID-Profile: Xiaoyi Chen, Huan Li, Shunlong Ou, Zhisan He, Dongni Zheng, Jing Luo, Qian Jiang
Zitieren
APA
Chen, X., Li, H., Ou, S., He, Z., Zheng, D., Luo, J., & Jiang, Q. (2026). Indication Expansion Dynamics and Trial Characteristics of Novel Multi-Indication Anti-Cancer Drugs in China (2000–2024): A Cross-Sectional Study. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s551402
Vancouver
Chen X, Li H, Ou S, He Z, Zheng D, Luo J, et al. Indication Expansion Dynamics and Trial Characteristics of Novel Multi-Indication Anti-Cancer Drugs in China (2000–2024): A Cross-Sectional Study. Drug Design, Development and Therapy. 2026. doi:10.2147/dddt.s551402
BibTeX
@article{Chen2026,
author = {Chen, Xiaoyi and Li, Huan and Ou, Shunlong and He, Zhisan and Zheng, Dongni and Luo, Jing and Jiang, Qian},
title = {Indication Expansion Dynamics and Trial Characteristics of Novel Multi-Indication Anti-Cancer Drugs in China (2000–2024): A Cross-Sectional Study},
journal = {Drug Design, Development and Therapy},
year = {2026},
doi = {10.2147/dddt.s551402}
}
EUVIMED